Specify a stock or a cryptocurrency in the search bar to get a summary
Evoke Pharma Inc
EVOKEvoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
Analytics
WallStreet Target Price
18 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EVOK
Dividend Analytics EVOK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EVOK
Stock Valuation EVOK
Financials EVOK
Results | 2019 | Dynamics |